Across TCGA pan-cancer cohorts, MIR503HG Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated MIR503HG data layer compared with 24 for mass-spec protein.

The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher MIR503HG Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated MIR503HG expression acts as an unfavorable survival marker.

OV are the cancer types where MIR503HG Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
OV	OS	Median	II,III,IV	0.308	0.691	.033	18	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

Exploration

Same gene, other analysis: MIR503HG tumor-vs-normal RNA expression · all MIR503HG data types